Anti-neoplastic cytotoxicity of SN-38-loaded PCL/Gelatin electrospun composite nanofiber scaffolds against human glioblastoma cells in vitro

Journal of Pharmaceutical Sciences

Volumn 104, Issue 12, 2015, Pages 4345-4354

  Zhu, Xiaodong ^a   Ni, Shilei ^a   Xia, Tongliang ^a   Yao, Qingyu ^a   Li, Haoyuan ^a   Wang, Benlin ^a   Wang, Jiangang ^a   Li, Xingang ^a   Su, Wandong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

biomaterial; blood brain barrier; in vitro models; nanotechnology; polymeric drug delivery systems

Indexed keywords

ACETIC ACID; FIRTECAN; GELATIN; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; ANTINEOPLASTIC AGENT; BIOMATERIAL; CAMPTOTHECIN; DELAYED RELEASE FORMULATION; IRINOTECAN; NANOFIBER; POLYESTER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; ELECTROSPINNING; ENCAPSULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; MISCIBILITY; MORPHOLOGY; WATER ABSORPTION; ANALOGS AND DERIVATIVES; CHEMISTRY; DELAYED RELEASE FORMULATION; MEMBRANE; METABOLISM; PHARMACOLOGY; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CAMPTOTHECIN; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DRUG LIBERATION; GELATIN; GLIOBLASTOMA; HUMANS; MEMBRANES; NANOFIBERS; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84954390633     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24684     Document Type: Article

References (26)

1. Allhenn D, Boushehri MA, Lamprecht A,. 2012. Drug delivery strategies for the treatment of malignant gliomas. Int J Pharm 436 (1-2): 299-310.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisaton for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group,. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (10): 987-96.
3. Sawaya R,. 1999. Extent of resection in malignant gliomas: A critical summary. J Neurooncol 42 (3): 303-305.
4. Seong H, An TK, Khang G, Choi SU, Lee CO, Lee HB,. 2003. BCNU-loaded poly (D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. Int J Pharm 251 (1-2): 1-12.
5. Lee JS, An TK, Chae GS, Jeong JK, Cho SH, Lee HB, Khang G,. 2005. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma. Eur J Pharm Biopharm 59 (1): 169-75.
6. McGovern PC, Lautenbach E, Brennan PJ, Lustig RA, Fishman NO,. 2003. Risk factors for postcraniotomy surgical site infection after 1, 3-bis (2-chloroethyl)-1-nitrosourea (gliadel) wafer placement. Clin Infect Dis 36 (6): 759-765.
7. Xie J, Wang CH,. 2006. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res 23 (8): 1817-1826.
8. Ni S, Fan X, Wang J, Qi H, Li X,. 2014. Biodegradable implants efficiently deliver combination of paclitaxel and temozolomide to glioma C6 cancer cells in vitro. Ann Biomed Eng 42 (1): 214-221.
9. Xue JX, Feng B, Zheng R, Lu Y, Zhou G, Liu W, Cao Y, Zhang Y, Zhang WJ,. 2013. Engineering ear-shaped cartilage using electrospun fibrous membranes of gelatin/polycaprolactone. Biomaterials 34 (11): 2624-231.
10. Xue JJ, He M, Liu H, Niu Y, Crawford A, Coates PD, Chen D, Shi R, Zhang L,. 2014. Drug loaded homogeneous electrospun PCL/gelatin hybrid nanofiber structures for anti-infective tissue regeneration membranes. Biomaterials 35 (34): 9395-9405.
11. Li Y, Ceylan M, Shrestha B, Wang H, Lu QR, Asmatulu R, Yao L,. 2014. Nanofibers support oligodendrocyte precursor cell growth and function as a neuron-free model for myelination study. Biomacromolecules 15 (1): 319-326.
12. Feng B, Tu H, Yuan H, Peng H, Zhang Y,. 2012. Acetic-acid-mediated miscibility toward electrospinning homogeneous composite nanofibers of GT/PCL. Biomacromolecules 10; 13 (12): 3917-325.
13. Bala V, Rao S, Boyd BJ, Prestidge CA,. 2013. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. J Control Release 172 (1): 48-61.
14. Carie A, Rios-Doria J, Costich T, Burke B, Slama R, Skaff H, Sill K,. 2011. IT-141, a polymer micelle encapsulating SN-38, induces tumor regression in multiple colorectal cancer models. J Drug Deliv 2011: 869027.
15. Peng CL, Lai PS, Lin FH, Yueh-Hsiu Wu S, Shieh MJ,. 2009. Dual chemotherapy and photodynamic therapy in an HT-29 human colon cancer xenograft model using SN-38-loaded chlorin-core star block copolymer micelles. Biomaterials 30 (21): 3614-3625.
16. Grassi M, Grassi G,. 2005. Mathematical modelling and controlled drug delivery: Matrix systems. Curr Drug Deliv 2 (1): 97-116.
17. Han J, Branford-White CJ, Zhu LM,. 2010. Preparation of poly (ε-caprolactone)/poly (trimethylene carbonate) blend nanofibers by electrospinning. Carbohyd Polym 79 (2010) 214-218.
18. Kim MS, Jun I, Shin YM, Jang W, Kim SI, Shin H,. 2010. The development of genipin-crosslinked poly (caprolactone) (PCL)/gelatin nanofibers for tissue engineering applications. Macromol Biosci 10 (1): 91-100.
19. Vangara KK, Ali HI, Lu D, Liu JL, Kolluru S, Palakurthi S,. 2014. SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer. AAPS PharmSciTech 15 (2): 472-482.
20. Meng ZX, Zheng W, Li L, Zheng YF,. 2010. Fabrication and characterization of three-dimensional nanofiber membrance of PCL-MWCNTs by electrospinning. Mater Sci Eng C 30 (2010) 1014-1021.
21. Zamani M, Morshed M, Varshosaz J, Jannesari M,. 2010. Controlled release of metronidazole benzoate from poly e-caprolactone electrospun nanofibers for periodontal diseases. Eur J Pharm Biopharm 75 (2): 179-185.
22. Yohe ST, Herrera VL, Colson YL, Grinstaff MW,. 2012. 3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells. J Control Release 162 (1): 92-101.
23. Wang W, Ghandi A, Liebes L, Louie SG, Hofman FM, Schonthal AH, Chen TC,. 2011. Effective conversion of irinotecan to SN-38 after intratumoral drug delivery to an intracranial murine glioma model in vivo. Laboratory investigation. J Neurosurg 114 (3): 689-694.
24. Puhl S, Ilko D, Li L, Holzgrabe U, Meinel L, Germershaus O,. 2014. Protein release from electrospun nonwovens: Improving the release characteristics through rational combination of polyester blend matrices with polidocanol. Int J Pharm 477 (1-2): 273-281.
25. Luong-Van E, Grøndahl L, Chua KN, Leong KW, Nurcombe V, Cool SM., 2006. Controlled release of heparin from poly (e-caprolactone) electrospun fibers. Biomaterials 27 (9): 2042-2050.
26. Bromberg LE, Ron ES,. 1998. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev 31 (3): 197-221.